Biotech Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.28 M
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit 80.53%
(FY 2023)
- Net Worth -0.02%
(FY 2023)
- Total Assets -0.07%
(FY 2023)
About Biotech Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹3.28 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Datla Renuka, Indira Rajupusapati, Mantena Purnima, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG1989PTC010050
- Company No.
010050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 1989
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationHyderabad, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biotech Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Datla Renuka  | Director | 28-May-1989 | Current |
| Indira Rajupusapati | Additional Director | 12-Apr-2013 | Current |
| Mantena Purnima | Director | 23-Jun-1989 | Current |
| Mahipal Saddi | Director | 28-Mar-2018 | Current |
| Rudaraju Kumar | Director | 28-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Biotech Pharma.
Biotech Pharma Pvt Ltd., for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.53% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biotech Pharma?
Unlock access to Biotech Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
V.R.Construction Pvt LtdActive 41 years 8 monthsDatla Renuka, Indira Rajupusapati and 1 more are mutual person
Biological E. LimitedActive 71 years 10 daysIndira Rajupusapati, Mantena Purnima and 1 more are mutual person
- Vaxenic India Private LimitedActive 9 years 10 months
Indira Rajupusapati, Mantena Purnima and 1 more are mutual person
Be Pharmaceuticals Private LimitedActive 13 years 3 monthsMahipal Saddi and Rudaraju Kumar are mutual person
D.A.P. Containers Private LimitedActive 48 years 1 monthDatla Renuka, Indira Rajupusapati and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
A.P.S.F.C. Creation Date: 03 May 1997 | ₹3.28 M | Satisfied |
How Many Employees Work at Biotech Pharma?
Unlock and access historical data on people associated with Biotech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
